Artisan Biomed

**Artisan Biomed** is a biotechnology startup based in **South Africa** that aims to revolutionize healthcare by unraveling the African genome. As a subsidiary of the Centre for Proteomic & Genomic Research (CPGR), it has established itself as one of Africa’s pioneer ‘omics’ service providers, propelling the region's capacity for information-rich biomedical research to a global standard. **Artisan Biomed** has forged a strategic partnership with **Lancet Laboratories** to capitalize on their combined strengths and capabilities in developing cutting-edge molecular solutions for the South African healthcare market. The company's primary focus lies in addressing the burgeoning demand for molecular testing services, particularly in non-communicable and rare genetic disorders, to provide actionable outcomes for both physicians and patients. **Artisan Biomed** aspires to introduce Precision Medicine in South Africa through four key solutions: 1. Making advanced molecular applications available to patients, enhancing disease management and healthcare at a cost-effective scale. 2. Providing ‘omics’ services to enrich clinical and translational research by creating an integrated and high-quality testing and data utilization environment. 3. Developing new medical diagnostic applications tailored for People of African Descent, leveraging advanced computational methodologies. 4. Offering training programs to empower stakeholders in utilizing Precision Medicine applications effectively. Founded in **2015**, the company is poised to unlock the potential of genomic medicine in South Africa. With its strategic vision and strong industry positioning, **Artisan Biomed** presents an attractive investment opportunity in the burgeoning African biotechnology sector.